1. Introduction
Infected eczema is a common and significant clinical complication of atopic dermatitis, characterized by the secondary invasion of bacteria, viruses, or fungi into skin that has been compromised by chronic inflammation. The bottom line up front is that the defective epidermal barrier and altered immune response inherent to eczema create an optimal environment for pathogens to thrive, requiring prompt clinical recognition and targeted antimicrobial therapy alongside standard eczema management to prevent systemic spread and severe tissue damage.
Atopic dermatitis is a chronic condition causing dry, pruritic (itchy), and inflamed skin. When the integrity of this skin is breached—often through the mechanical trauma of scratching—microorganisms that normally reside harmlessly on the skin surface or in the environment can penetrate deeper dermal layers. Understanding the specific pathogens involved and the biological vulnerabilities of eczematous skin is essential for effective treatment.
2. Pathophysiology of the Skin Barrier
Healthy skin functions as a highly effective barrier, utilizing tightly packed cells (keratinocytes) embedded in a lipid-rich matrix to keep moisture in and pathogens out. In individuals with eczema, this barrier is inherently defective. Genetic mutations, notably in the filaggrin gene, lead to a reduction in crucial structural proteins and epidermal lipids.
This structural deficiency results in increased transepidermal water loss, leaving the skin profoundly dry and porous. These microscopic gaps in the barrier allow environmental allergens, irritants, and microorganisms to penetrate into the deeper layers of the epidermis, triggering a continuous, hyperactive inflammatory response by the local immune cells.
3. Altered Skin Microbiome
The surface of the human body is colonized by a diverse community of bacteria, fungi, and viruses collectively known as the microbiome. In a healthy state, these microorganisms exist in a delicate balance, competing for resources and preventing pathogenic species from dominating.
In eczematous skin, this microbial diversity is significantly reduced. The inflammatory environment and a documented decrease in the production of natural antimicrobial peptides (such as cathelicidins and beta-defensins) allow specific, opportunistic bacteria to proliferate rapidly, overwhelming the commensal flora and establishing a dominant, pathogenic presence.
4. The Role of Staphylococcus aureus
The most frequent culprit in bacterial infections of eczema is *Staphylococcus aureus*. Clinical studies indicate that up to ninety percent of patients with moderate to severe atopic dermatitis have skin colonized by *S. aureus*, compared to less than five percent of healthy individuals.
*S. aureus* exacerbates the underlying disease process by secreting specific toxins known as superantigens. These superantigens directly stimulate the immune system, provoking a massive release of inflammatory cytokines. This creates a destructive feedback loop: the inflammation worsens the skin barrier defect, which in turn promotes further bacterial colonization and deeper tissue invasion.
5. Clinical Signs of Bacterial Infection
Distinguishing a standard eczema flare from a secondary bacterial infection requires careful clinical observation. A standard flare involves redness, scaling, and intense itching. When a bacterial infection supervenes, the physical characteristics of the lesions change distinctly.
The hallmark signs of bacterial infection include the sudden appearance of increased redness, swelling, and localized warmth. The lesions frequently begin to weep clear or purulent (pus-filled) fluid, which dries into characteristic golden or honey-colored crusts. The patient may also experience increased pain and tenderness in the affected areas, rather than just pruritus.
6. Eczema Herpeticum: A Viral Complication
While bacterial infections are the most common, viral infections pose a particularly severe threat. Eczema herpeticum is a potentially life-threatening complication caused by the disseminated spread of the Herpes Simplex Virus (typically HSV-1) across eczematous skin.
Because the skin lacks robust antiviral defenses, the virus spreads rapidly, causing a sudden eruption of uniform, punched-out, fluid-filled vesicles that quickly rupture and leave painful, hemorrhagic crusts. Eczema herpeticum is a dermatological emergency that can lead to systemic viremia, organ involvement, and severe ocular complications if the virus spreads to the eyes.
7. Fungal Superinfections
Fungal organisms, particularly the yeast *Malassezia* and various dermatophytes (ringworm), can also exploit the compromised barrier of eczematous skin. *Malassezia* naturally resides on the skin but can proliferate abnormally in patients with eczema, particularly on the head, neck, and upper trunk.
Fungal superinfections often present as well-demarcated, highly pruritic, circular plaques with a scaly border. They may not respond to standard topical corticosteroids and require specific antifungal interventions. Diagnosis often involves a potassium hydroxide (KOH) preparation of skin scrapings examined under a microscope.
8. The Itch-Scratch Cycle
The relentless pruritus associated with eczema is a primary driver of secondary infections. The mechanical action of scratching provides transient relief by stimulating pain receptors that temporarily override the itch signals. However, scratching inflicts severe physical trauma on the skin.
This excoriation physically drives surface bacteria deeper into the dermal layers. It also causes micro-hemorrhages and serum exudation, providing a nutrient-rich environment for bacterial growth. Breaking the itch-scratch cycle through behavioral modification and pharmacological intervention is a paramount clinical objective. This approach is heavily utilized in comprehensive chronic skin inflammation management protocols.
9. Systemic Symptoms and Risks
While most infected eczema remains localized to the skin, severe or untreated infections can spread, leading to systemic involvement. A localized bacterial infection can progress into deep tissue cellulitis, characterized by rapidly spreading redness, deep pain, and swelling of an entire limb.
Systemic symptoms indicate that the infection has entered the bloodstream or lymphatic system. These include the onset of a fever, chills, profound fatigue, and the enlargement of regional lymph nodes (lymphadenopathy). The presence of systemic symptoms necessitates immediate medical evaluation and systemic antimicrobial therapy.
10. Diagnostic Evaluation
The diagnosis of infected eczema is predominantly clinical, based on a detailed patient history and physical examination. The physician will assess the extent of the crusting, weeping, and localized signs of inflammation.
In cases where the infection does not respond to initial empirical therapy, or if recurrent infections occur, a bacterial swab is frequently obtained. The swab is sent to a microbiology laboratory for culture and sensitivity testing. This precisely identifies the causative organism and determines which specific antibiotics will be most effective, a crucial step in the era of rising antibiotic resistance, such as Methicillin-resistant *Staphylococcus aureus* (MRSA).
| Pathogen Type | Primary Organism | Classic Clinical Presentation |
|---|---|---|
| Bacterial | Staphylococcus aureus | Weeping fluid, golden/honey-colored crusts, localized pain, pus. |
| Viral | Herpes Simplex Virus | Rapid onset of uniform, punched-out blisters, painful hemorrhagic crusts, fever. |
| Fungal | Malassezia, Dermatophytes | Scaly, circular plaques, poor response to standard eczema creams. |
11. Topical Antimicrobial Therapy
For mild, localized bacterial infections, topical antimicrobial agents are the first line of defense. Medications such as mupirocin or fusidic acid are applied directly to the crusted lesions.
These topical agents deliver a high concentration of the antibiotic directly to the site of infection while minimizing systemic absorption and potential side effects. They are typically prescribed for a short course of five to ten days. Concurrently, the patient is advised to continue using topical corticosteroids to manage the underlying eczema inflammation, often applying the steroid after the antibiotic.
12. Oral Antimicrobial Management
When the infection is widespread, involves deep tissues, or is accompanied by systemic symptoms like fever, oral antibiotics are indicated. The choice of antibiotic is initially empirical, targeting the most likely pathogens (*Staphylococcus* and *Streptococcus* species).
Commonly prescribed oral antibiotics include cephalexin or flucloxacillin. If MRSA is suspected based on local prevalence or the patient’s medical history, alternative agents such as clindamycin or trimethoprim-sulfamethoxazole may be utilized. Patients must complete the entire prescribed course to ensure the infection is fully eradicated and to prevent bacterial resistance.
13. Antiviral Interventions
If a viral infection, specifically eczema herpeticum, is suspected, immediate treatment with systemic antiviral medication is mandatory. Oral acyclovir or valacyclovir is initiated promptly to halt viral replication.
In severe cases involving infants, pregnant women, or immunocompromised individuals, hospitalization for intravenous acyclovir and close clinical monitoring may be necessary. Topical corticosteroids are generally paused or used with extreme caution during an active viral outbreak to avoid further suppressing the local immune response against the virus.
14. Dilute Bleach Baths
A highly effective adjunctive therapy for patients prone to recurrent bacterial infections is the implementation of dilute bleach baths. This protocol involves adding a precise, very small amount of household bleach (sodium hypochlorite) to a full bathtub of lukewarm water.
The resulting solution mimics the concentration of a swimming pool and acts as a mild, broad-spectrum antimicrobial agent. Soaking in a dilute bleach bath for ten minutes a few times a week significantly reduces the bacterial load on the skin surface, lowering the rate of *S. aureus* colonization and preventing future clinical infections.
15. Restoring the Skin Barrier
Treating the acute infection is only one component of comprehensive care; restoring and maintaining the epidermal barrier is critical for preventing recurrences. Patients must adhere to a strict daily regimen of emollient therapy.
Medical-grade moisturizers (ointments or thick creams) should be applied generously multiple times a day, particularly immediately after bathing, to trap moisture and reinforce the lipid barrier. Harsh soaps and detergents must be avoided, replaced by gentle, soap-free cleansers. This diligent maintenance therapy reduces overall inflammation and makes the skin less hospitable to pathogenic microbes.
16. Frequently Asked Questions (FAQ)
1. How can I tell if my eczema is infected or just flaring up?
A standard flare is itchy, red, and dry. An infection typically causes the skin to become very painful, warmer to the touch, and weep clear or yellow fluid that dries into golden crusts. The sudden appearance of small, painful blisters can also indicate a viral infection.
2. Should I stop using my steroid cream if my skin is infected?
For a bacterial infection, doctors usually recommend continuing the steroid cream alongside an antibiotic to calm the underlying inflammation. However, if a viral infection (like the herpes virus) is suspected, your doctor may advise pausing the steroid temporarily. Always follow your physician’s specific instructions.
3. Are bleach baths safe for infected skin?
Yes, when prepared correctly. A dilute bleach bath uses a very small amount of bleach in a full tub of water, making it similar to swimming pool water. It is a safe, medically approved way to gently reduce the bacteria on the skin and prevent recurrent infections.
4. Can an eczema infection spread to other people?
The eczema itself is not contagious. However, the bacteria or viruses causing the secondary infection can be spread through direct skin-to-skin contact or by sharing towels. Good hand hygiene is essential.
5. When should I seek immediate emergency care for infected eczema?
You should seek immediate medical attention if the redness spreads rapidly, if you develop a fever or chills, if the infection is near the eyes, or if there is a sudden outbreak of painful, fluid-filled blisters across the skin.
17. Bibliography
Disclaimer: The content is for informational purposes only and does not replace medical advice. Always consult your doctor for personalized treatment.
